Separately, the US drugmaker said data from a new study showed a combination of two of its antibody treatments helped reduce hospitalization and emergency room visits for COVID-19 patients.
Eli Lilly applies for FDA emergency use of COVID-19 treatment
By YOAV ETIEL
01/04/2025 02:45 AM
By REUTERS
01/03/2025 10:36 PM
By REUTERS
01/03/2025 10:33 PM
By REUTERS
01/03/2025 07:49 PM
By REUTERS
01/03/2025 07:33 PM
By REUTERS
01/03/2025 05:13 PM